Saw Palmetto for Urinary Tract Health

Research suggests that saw palmetto extract has shown mixed results for urinary tract health, particularly in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. A 2004 review and a 2025 randomized controlled trial found meaningful improvements in urinary frequency and symptom bother, and a 2019 systematic review identified favorable effects alongside other lifestyle and supplement interventions, while laboratory and network pharmacology studies point to plausible biological mechanisms involving anti-androgenic, anti-inflammatory, and hormone-signaling pathways. However, a well-designed 2011 randomized controlled trial found that saw palmetto performed no better than placebo even at higher-than-standard doses, multiple reviews characterize the overall clinical evidence as inconsistent, and a 2023 clinical overview concluded the supplement lacks sufficient evidence of benefit, with reviewers frequently attributing variability in outcomes to the absence of standardized extract formulations. The body of evidence spans randomized controlled trials, systematic reviews, and mechanistic laboratory studies, but the mixed direction of results across higher-quality trials means firm conclusions remain elusive, and further well-standardized clinical research is needed before the supplement's role in urinary health can be clearly established.